Lubeck M D, Steplewski Z, Baglia F, Klein M H, Dorrington K J, Koprowski H
J Immunol. 1985 Aug;135(2):1299-304.
The use of murine monoclonal antibodies in the immunotherapy of human disease has prompted interest in the interactions of murine IgG with Fc receptors (FcR) expressed on human effector cells. We examined the heterocytophilic interactions between monomeric murine IgG subclass proteins and the FcR expressed on human monocytic cells (peripheral blood monocytes and interferon (IFN)-gamma-induced U937 cells). All four murine IgG2a antibodies and both murine IgG3 antibodies that were tested bound to human monocyte FcR with high affinity (10(8) to 10(9) M-1). By contrast, the affinities of four murine IgG1 and four IgG2b monomers were 100-fold to 1000-fold lower than the affinity of the human IgG1-FcR interaction. A 68,000 to 72,000 dalton protein was isolated by affinity chromatography from blood monocytes and from IFN-gamma-induced U937 cells on murine IgG2a, IgG3, and human IgG immunoadsorbents. In binding assays with IFN-stimulated U937 cells, murine IgG2a and IgG3 antibodies showed complete cross-blocking with a human IgG1 myeloma protein, indicating that murine and human IgG interact with the same population of Fc-binding proteins. No evidence for heterogeneity of cross-reactive FcR was observed. The ability of murine IgG2a and IgG3 monomers to compete with human IgG1 monomers for binding to human monocyte FcR suggests the potential usefulness of antibodies of these isotypes in the immunotherapy of diseases in which monocyte- or macrophage-mediated, antibody-dependent cellular cytotoxicity may play a role in the modification or remission of disease.
鼠单克隆抗体在人类疾病免疫治疗中的应用引发了人们对鼠IgG与人类效应细胞上表达的Fc受体(FcR)相互作用的兴趣。我们研究了单体鼠IgG亚类蛋白与人类单核细胞(外周血单核细胞和干扰素(IFN)-γ诱导的U937细胞)上表达的FcR之间的嗜异性相互作用。所测试的所有四种鼠IgG2a抗体和两种鼠IgG3抗体都以高亲和力(10⁸至10⁹ M⁻¹)与人单核细胞FcR结合。相比之下,四种鼠IgG1和四种IgG2b单体的亲和力比人IgG1-FcR相互作用的亲和力低100倍至1000倍。通过亲和层析从血液单核细胞以及IFN-γ诱导的U937细胞中,利用鼠IgG2a、IgG3和人IgG免疫吸附剂分离出一种68,000至72,000道尔顿的蛋白质。在与IFN刺激的U937细胞的结合试验中,鼠IgG2a和IgG3抗体与人IgG1骨髓瘤蛋白表现出完全交叉阻断,表明鼠IgG和人IgG与同一群体的Fc结合蛋白相互作用。未观察到交叉反应性FcR异质性的证据。鼠IgG2a和IgG3单体与人IgG1单体竞争结合人单核细胞FcR的能力表明,这些同种型的抗体在某些疾病的免疫治疗中可能具有潜在用途,在这些疾病中单核细胞或巨噬细胞介导的抗体依赖性细胞毒性可能在疾病的改善或缓解中发挥作用。